Standout Papers

HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular Events 2007 2026 2013 2019 1.2k
  1. HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular Events (2007)
    Philip J. Barter, Antonio M. Gotto et al. New England Journal of Medicine
  2. Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease (2020)
    Deepak L. Bhatt, Michael Szarek et al. New England Journal of Medicine
  3. Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a) (2024)
    Steven E. Nissen, Qiuqing Wang et al. JAMA
  4. Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure (2020)
    Deepak L. Bhatt, Michael Szarek et al. New England Journal of Medicine

Immediate Impact

1 by Nobel laureates 12 from Science/Nature 68 standout
Sub-graph 1 of 19

Citing Papers

Diabetes mellitus—Progress and opportunities in the evolving epidemic
2024 Standout
Foundation models for generalist medical artificial intelligence
2023 StandoutNature
1 intermediate paper

Works of Michael Szarek being referenced

Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
2020 Standout
Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial
2019

Author Peers

Author Last Decade Papers Cites
Michael Szarek 3713 2204 661 3156 120 7.0k
Gérald Luc 3067 2947 629 2544 87 8.9k
Steven R. Jones 3029 1924 438 2503 179 7.2k
H. Schulte 3169 2569 345 3155 126 7.9k
Marianne Benn 3951 2496 420 3147 117 8.3k
Heinz Drexel 4122 2471 1129 2580 295 8.4k
A R Lorimer 5843 2714 1612 3194 111 9.3k
Hanna E. Bloomfield 4601 2002 675 3767 81 8.3k
Benoît J. Arsenault 3071 3087 329 2259 167 8.2k
B. Greg Brown 5125 3644 466 2132 100 8.5k
Sergio Fazio 4418 1845 796 2197 141 7.7k

All Works

Loading papers...

Rankless by CCL
2026